Clinical efficacy and follow up of drug eluting stent treatment for 120 unprotected left main coronary artery lesions

LU Ming-yu,YE Hui-ming,WANG Wei-min,LIU Jian,ZHAO Hong,MA Yu-liang,LI Qi,LIU Chuan-fen
DOI: https://doi.org/10.3969/j.issn.1004-8812.2012.01.012
2012-01-01
Abstract:Objective To explore the clinical efficacy of drug eluting stent(DES) in treating patients with unprotected left main coronary artery lesions(LMCA).Methods A total of 120 unprotected LMCA patients treated with DES between March 2007 and November 2010 were classified as bifurcation group(n=80) and non-bifurcation group(n=40).Both groups received single stenting or double stenting according to the lesions characteristics.Intravascular ultrasonic(IVUS) were more commonly used in bifurcation group than non-bifurcation group during stenting.The procedure characteristics of each group,and the major adverse cardiac event(MACE)(including death,myocardial infarction and target lesion revascularization(TLR) and stent thrombosis(ST) during period of in-hospital and follow-up were analyzed.Results Most of the clinical baseline conditions were similar between both groups.More patients received IVUS guiding in stenting for bifurcation group(but P>0.05).106(88.3%) patients completed follow up with a duration of(26.3±14.5) months.33 patients in bifurcation group had double stenting technique and only 5 patients in non-bifurcation group(P=0.001).No MACE and ST occured in hospital.Rates of MACE at the end of follow-up were not significantly statistical differences between the two groups(7.5% vs.12.5%,χ2=0.801,P=0.503).One case of ST was recorded in both groups.The total occurrence of death,myocardial infarction,TLR and MACE were 2.8%,1.9%,5.6% and 9.2% respectively.All death patients had both high SYNTAX scores and high EuroSCORE.Conclusion DES treatment is a safe and feasible alternative for unprotected LMCA patients regardless of bifurcation or not during a short and long period follow up.
What problem does this paper attempt to address?